Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy. [electronic resource]
Producer: 20161213Description: 378-85 p. digitalISSN:- 1478-3231
- Adult
- Aged
- Cognition -- drug effects
- Female
- Hepatic Encephalopathy -- diagnosis
- Humans
- India
- Lactulose -- adverse effects
- Liver Cirrhosis -- complications
- Male
- Middle Aged
- Neuropsychological Tests
- Prospective Studies
- Psychometrics
- Quality of Life
- Rifamycins -- adverse effects
- Rifaximin
- Sickness Impact Profile
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.